New report assesses impact of physical inactivity on UK heart health and economy

April 24, 2017

Source: British Heart Foundation

Follow this link for full text

Date of publication: April 2017

Publication type: Report

In a nutshell: A report by the British Heart Foundation finds that more than 20 million adults in the UK are physically inactive and estimates that this increase risk of heart disease may cost the NHS £1.2 billion annually.

Length of publication: 1 webpage

Some important notes: Please contact your local NHS library if you cannot access the full text. Follow this link to find your local NHS library.

Acknowledgement:  British Heart Foundation              

Advertisements

The cost effectiveness of ivabradine in the treatment of chronic heart failure

June 19, 2014

Source: Heart, 2014, 100 (13) p. 1031-6

Follow this link for fulltext

Date of publication: July 2014

Publication type: Journal article

In a nutshell: This economic evaluation assessed the cost-effectiveness of ivabradine from the perspective of the UK National Health Service, based on the results of the SHIfT trial. Ivabradine is expected to have a 95% chance of being cost-effective in the EU-licensed population using the current NICE cost-effectiveness threshold of £20,000 per QALY.

Length of publication: 6 pages

Some important notes: Please contact your local NHS library if you cannot access the full text. Follow this link to find your local NHS library.


The cost effectiveness of ivabradine in the treatment of chronic heart failure

March 17, 2014

Source: Heart Online First

Follow this link for fulltext

Date of publication: March 2014

Publication type: Journal article

In a nutshell: This economic evaluation suggests that use of the drug ivabradine for heart failure (HF) is cost-effective for patients with HF.

Length of publication: 6 pages

Some important notes: Please contact your local NHS library if you cannot access the full text. Follow this link to find your local NHS library.